Thailand Pharmaceutical Consulting

Thailand’s pharmaceutical market is worth about $2 billion. A good understanding of Thailand’s healthcare dynamics will help international pharmaceutical companies do well in this drug market. PBM has worked on various pharmaceutical consulting projects in Thailand. We have helped international companies in sourcing APIs, marketing new drugs, setting up joint ventures and finding local drug distributors in Thailand.

According to the World Health Organization, Thailand’s pharmaceutical market has more than 170 manufacturing facilities and almost 500 drug importers. Most of Thailand’s drug production is for the domestic market, although pharmaceutical exports are gradually increasing. With a limited budget, the Thai government has been strongly encouraging the use of generics drug over patented drugs. The Thai government also imports generic drugs, where local drugs are unavailable. These imports are mainly from India. The most prevalent chronic illnesses in Thailand are diabetes and hypertension, while the leading causes of deaths are cancer, stroke, diabetes and cardiovascular disease. International drug companies looking to export their products to Thailand can contact PBM’s pharmaceutical consultants for assistance and professional guidance on the necessary procedures.

Thailand’s pharmaceutical market is regulated by the Thai Food and Drug Administration (FDA), which falls under the Ministry of Public Health. Licenses from the Thai FDA are required for importing, manufacturing or selling pharmaceutical products.

With years of experience in medical consulting, PBM’s Thailand pharmaceutical consultants are knowledgeable and goal-oriented professionals who focus on helping international companies succeed. For inquiries about PBM’s Thailand pharmaceutical consultant services, please contact us or view PBM’s publications for more articles on Thailand’s healthcare market.